The journal of obstetrics and gynaecology researchHumansFemaleAntibodiesMonoclonalHumanized
Successful Rechallenge With Pembrolizumab After a Grade 3 Infusion Reaction With a Far Slower Infusion Rate and Premedication: A Case Report.
Takashi Uehara, Kanae Tahatsu, Satomi Aoyama, Ryutaro Yamada, Shinichiro Minobe
Published: 202510.1111/jog.70101
Abstract
Patients who experience grade 3 and 4 infusion reactions during pembrolizumab treatment should discontinue treatment, per the prescribing guidelines. We report a case of successful rechallenge with pembrolizumab after a grade 3 infusion reaction with…
Preview only. Read the full abstract at the source